SearchPublisher and Institutes
You are here: Home :: Keyword index :: ray bis sof :: riboflavin synthase - risk management 
risk factors
Items for "risk factors"
Idiopathic venous thrombosis. Long-term anticoagulant therapy? No
Venous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding...
Keywords: Venöse Thrombose, Rezidiv, sekundäre Thromboseprophylaxe, Vitamin-K-Antagonisten, Risikofaktoren
01/2006 | Hämostaseologie, SchattauerStroke: epidemiology, risk factors, and genetics
Stroke constitutes a major global challenge for health policy and healthcare economics. Reducing stroke burden requires extensive knowledge of risk factors and, if applicable, preventive control...
Keywords: Schlaganfall, Epidemiologie, Risikofaktoren, Genetik
01/2006 | Hämostaseologie, SchattauerNew concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism
Recent trials on secondary prophylaxis after venous thromboembolism (VTE) have provided a wealth of data on the risk factors for recurrence and, to some extent, also for bleeding...
Keywords: Venous thromboembolism, risk factors, recurrence, bleeding
09/2006 | Thrombosis and Haemostasis, SchattauerThe gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly influence thrombus formation and degradation and thus risk for arterial thrombosis...
Keywords: epidemiological studies, thrombosis, risk factors, plasminogen, sex
10/2006 | Thrombosis and Haemostasis, SchattauerHigh frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis
Among candidate risk factors associated with postoperative venous thromboembolism (VTE), the role of factorV Leiden (FVL) mutation remains unclear...
Keywords: Venous thromboembolism, pulmonary embolism, factor V Leiden, surgery, orthopaedic surgery, risk factors
00/0000 | Thrombosis and Haemostasis, SchattauerThe 11377 C > G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men
No prospective data demonstrating an association between the 11377 C > G adiponectin gene promoter variant and cardiovascular risk are available...
Keywords: coronary artery disease, angiography, risk factors, cytokines, epidemiology
03/2007 | Thrombosis and Haemostasis, SchattauerElevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
The endothelium plays a crucial role in the maintenance of vascular tone and structure by releasing the endothelium-derived vasoactive mediator, nitric oxide (NO)...
Keywords: coronary heart disease, endothelium, nitric oxide, Prognosis, risk factors
10/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterOxidative stress evaluated using an automated method for hydroperoxide estimation in patients with coronary artery disease
Keywords: atherosclerosis, coronary artery disease, diabetes, hydroperoxides, oxidative stress, risk factors
03/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterHypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease
There is growing evidence that adiponectin, an adipocytokine with anti-inflammatory and antiathero-genic properties, is involved in the development of atherosclerosis...
Keywords: adiponectin, atherosclerosis, peripheral vascular disease, risk factors
07/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterEfficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis
Keywords: Antibiotic prophylaxis, early onset sepsis, female, Group B streptococcus, Newborn, pregnancy complications, risk factors, streptococcal infections/pc [prevention & control], Streptococcus agalactiae, Switzerland
02/2006 | Journal of Perinatal Medicine, Walter de GruyterThe new role of D-dimer as a predictor of recurrent venous thromboembolism D-Dimere: Ihre neue Rolle als Prädiktoren für rezidivierende venöse Thromboembolien
Venous thromboembolism (VTE) tends to recur after oral anticoagulant therapy (OAT) withdrawal, regardless of the duration of treatment...
Keywords: D-Dimer, Fibrin-Fibrinogen-Degradationsprodukte, orale Antikoagulanzien, Risikofaktoren, venöse Thromboembolie
12/2005 | LaboratoriumsMedizin, Walter de Gruyter